Naphthyloxy acetic acid derivatives and a pharmaceutical composition comprising them as an active ingredient
Abstract
The naphthyloxyacetic acid derivatives of the formula (I) wherein A is H, -(alkylene)COOR 1 , -(alkylene)CONR 2 R 3 , -(alkylene)OH, -(alkylene)tetrazole, -(alkylene)CN; E is single bond or alkylene; G is —S—, —SO—, —SO 2 —, —O— or —NR 4 —; L is alkylene, —(CH 2 ) m —CH═CH—(CH 2 ) n — or —(CH 2 ) x —CH(OH)—(CH 2 ) y —; M is phenyl, phenyl(thio, oxy, amino), diphenylmethyl, diphenylmethyl(thio, oxy, amino), and pharmaceutical composition comprising them as an active ingradient. The compounds of the formula (I) can combine PGE 2 receptor and exhibit the activity to antagonize or agonize for PGE 2 receptor. Therefore, they are useful as anti-hyperlipemia, for the prevention of abortion, for analgesics, as antidiarrheals, sleep inducer, diuretic, anti-diabetes, abortient, cathartics, antiulcer, anti-gastritis or antihypertensive etc.
Claims
exact text as granted — not AI-modifiedWhat we claim is:
1 ) A naphthyloxyacetic acid derivative of the general formula. (I)
wherein A is
(i) hydrogen,
(ii) —(C1-4 alkylene)—COOR 1 in which R 1 is hydrogen or C1-4 alkyl,
(iii) —(C1-4 alkylene)—CONR 2 R 3 in which R 2 and R 3 each, independently, is hydrogen or C1-4 alkyl,
(iv) —(C1-4 alkylene)—OH,
(v) —(C1-4 alkylene)-tetrazolyl or
(vi) —(C1-4 alkylene)—CN;
E is (i) single bond or
(ii) C1-6 alkylene;
G is —S—, —SO—, —SO 2 —, —O— or —NR 4 — in which, R 4 is hydrogen or C1-4 alkyl;
L is (i) C1-6 alkylene,
(ii) R-(CH 2 ) m —CH═CH—(CH 2 ) n — in which m is 0 or an integer of 1-3, n is 0 or an integer of 1-3 or
(iii) —(CH 2 ) x —CH(OH)—(CH 2 ) y — in which x is an integer of 1-3, y is 0 or an integer of 1-3;
M is
in which each phenyl group may be substituted by 1-3 of C1-4 alkyl, C1-4 alkoxy, halogen, nitro or trifluoromethyl;
in the formula
is single bond or double bond;
with the proviso that,
(1) when G is —SO— or —SO 2 —, M is neither
in which each phenyl group may be substituted by 1-3 of C1-4 alkyl, C1-4 alkoxy, halogen, nitro or trifluoromethyl,
(2) when m in L is 0, G is —SO— or —SO 2 —,
(3) when n in L is 0, M is
in which each phenyl group may be substituted by 1-3 of C1-4 alkyl, C1-4 alkoxy, halogen, nitro or trifluoromethyl,
(4) when y in L is 0, M is
in which each phenyl group may be substituted by 1-3 of C1-4 alkyl, C1-4 alkoxy, halogen, nitro or trifluoromethyl,
(5) when A is hydrogen, L is —(CH 2 ) m —CH═CH—(CH 2 ) n — or —(CH 2 ) x —CH(OH)—(CH 2 ) y — in which m, n, x and y are the same meaning as defined in claim 1 , and
(6) tetrazolyl in A is
or non-toxic salt thereof, non-toxic acid addition salt thereof or their hydrate.
2 ) A compound according to claim 1 , wherein A is —(C1-4 alkylene)—COOR 1 .
3 ) A compound according to claim 1 , wherein A is —(C1-4 alkylene)—CONR 2 R 3 , —C1-4 alkylene)—OH, —(C1-4 alkylene)-tetrazolyl or —(C1-4 alkylene)—CN.
4 ) A compound according to claim 1 , wherein A is hydrogen.
5 ) A compound according to claim 1 - 5 , wherein L is —(CH 2 ) m —CH═CH—(CH 2 ) n —or —(CH 2 ) x —CH(OH)—(CH 2 ) y —.
6 ) A compound according to claim 5 , wherein G is —S—, —SO— or —SO 2 —.
7 ) A compound according to claim 5 , wherein G is —O—.
8 ) A compound according to claim 5 , wherein G is —NR 4 —.
9 ) A compound according to claim 6 , which is
(1) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-phenoxy-2RS-propanol, (2) 1-[2-(5-hydroxy-1-naphthyl)ethylsulfinyl]-3-phenoxy-2RS-propanol, (3) 1-[2-(5-hydroxy-1-naphthyl)ethylsulfonyl]-3-phenoxy-2RS-propanol, (4) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-phenoxy-2R-propanol, (5) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-phenoxy-2S-propanol, (6) 1-(5-hydroxy-1-naphthyl)methylthio-3-phenoxy-2RS-propanol, (7) 1-(5-hydroxy-1-naphthyl)methylsulfinyl-3-phenoxy-2RS-propanol, (8) 1-(5-hydroxy-1-naphthyl)methylsulfonyl-3-phenoxy-2RS-propanol, (9) 2-[3-(5-hydroxy-1-naphthyl)propylthio]-1-phenyl-1 RS-ethanol, (10) 2-[3-(5-hydroxy-1-naphthyl)propylsulfinyl]-1-phenyl-1 RS-ethanol, (11) 2-[3-(5-hydroxy-1-naphthyl)propylsulfonyl]-1-phenyl-1 RS-ethanol, (12) 1-(5-hydroxy-1-naphthyl)thio-3-phenoxy-2RS-propanol, (13) 1-(5-hydroxy-1-naphthyl)sulfinyl-3-phenoxy-2RS-propanol, (14) 1-(5-hydroxy-1-naphthyl)sulfonyl-3-phenoxy-2RS-propanol, (15) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-(4-chlorophenoxy)-2RS-propanol, (16) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-(4-methylphenoxy)-2RS-propanol, (17) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-(4-methoxyphenoxy)-2RS-propanol, (18) 1-[2-(5-hydroxy-1-naphthyl)ethylthiol-3-diphenylmethoxy-2RS-propanol, (19) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-[1-phenyl-1-(4-chlorophenyl)-methoxy]-2RS-propanol, (20) 1-[2-(5-hydroxy-1-naphthyl)ethylthio]-3-phenylthio-2RS-propanol, (21) 1-(5-hydroxy-1-naphthyl)methylthio-3-diphenylmethoxy-2RS-propanol, (22) 1-(5-hydroxy-1-naphthyl)methylthio-3-[1-phenyl-1-(4-chlorophenyl)-methoxy]-2RS-propanol, (23) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylthio)ethyl]-1-naphthyloxy}-acetic acid methyl ester, (24) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylsulfinyl)ethyl]-1-naphthyloxy}acetic acid methyl ester, (25)2-{5-[2-(2RS-hydroxy-3-phenoxypropylsulfonyl)ethyl]-1-naphthyloxy}-acetic acid methyl ester, (26) 2-{5-(2-(2R-hydroxy-3-phenoxypropylthio)ethyl]-1-naphthyloxy}acetic acid methyl ester, (27) 2-{5-[2-(2S-hydroxy-3-phenoxypropylthio)ethyl]-1-naphthyloxy}acetic acid methyl ester, (28) 2-[5-(2RS-hydroxy-3-phenoxypropylthio)methyl-1-naphthyloxy]acetic acid methyl ester, (29) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfinyl)methyl-1-naphthyloxy]acetic acid methyl ester, (30) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfonyl)methyl-1-naphthyloxy]acetic acid methyl ester, (31) 2-{5-[3-(2RS-hydroxy-2-phenylethylthio)propyl]-1-naphthyloxy}acetic acid methyl ester, (32) 2-{5-[3-(2RS-hydroxy-2-phenylethylsulfinyl)propyl]-1-naphthyloxy}acetic acid methyl ester, (33) 2-{5-[3-(2RS-hydroxy-2-phenylethylsulfonyl)propyl]-1-naphthyloxy}acetic acid methyl ester, (34) 2-[5-(2RS-hydroxy-3-phenoxypropylthio)-1-naphthyloxy]acetic acid methyl ester, (35) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfinyl)-1-naphthyloxy]acetic acid methyl ester, (36) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfonyl)-1-naphthyloxy]acetic acid methyl ester, (37) 2-[5-(3-styrylsulfonylpropyl)-1-naphthyloxy]acetic acid methyl ester, (38) 2-[5-(3-styrylsulfinylpropyl)-1-naphthyloxy]acetic acid methyl ester, (39) 2-{5-[2-(2RS-hydroxy-3-(4-chlorophenoxy)propylthio)ethyl]-1-naphthyloxy}acetic acid methyl ester, (40) 2-{5-[2-(2RS-hydroxy-3-(4-methylphenoxy)propylthio)ethyl]-1-naphthyloxy}acetic acid methyl ester, (41) 2-{5-[2-(2RS-hydroxy-3-(4-methoxyphenoxy)propylthio)ethyl]-1-naphthyloxy}acetic acid methyl ester, (42) 2-{5-[2-(2RS-hydroxy-3-diphenylmethoxypropylthio)ethyl]-1-naphthyloxy}-acetic acid methyl ester, (43) 2-{5-[2-(2RS-hydroxy-3-(1-phenyl-1-(4-chlorophenyl)methoxy)propylthio)-ethyl]-1-naphthyloxy}acetic acid methyl ester, (44) 2-{5-[2-(2RS-hydroxy-3-phenylthiopropylthio)ethyl]-1-naphthyloxy}acetic acid methyl ester, (45) 2-[5-(2RS-hydroxy-3-diphenylmethoxypropylthio)methyl-1-naphthyloxy]-acetic acid methyl ester, (46) 2-{5-[2RS-hydroxy-3-(1-phenyl-1-(4-chlorophenyl)methoxy)propylthio]-methyl-1-naphthyloxy}acetic acid methyl ester, (47) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylthio)ethyl]-1-naphthyloxy}-acetic acid, (48) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylsulfinyl)ethyl]-1-naphthyloxy}acetic acid, (49) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylsulfonyl)ethyl]-1-naphthyloxy}-acetic acid, (50) 2-{5-[2-(2R-hydroxy-3-phenoxypropylthio)ethyl]-1-naphthyloxy}-acetic acid, (51) 2-{5-[2-(2S-hydroxy-3-phenoxypropylthio)ethyl]-1-naphthyloxy}-acetic acid, (52) 2-[5-(2RS-hydroxy-3-phenoxypropylthio)methyl-1-naphthyloxy]-acetic acid, (53) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfinyl)methyl-1-naphthyloxy]acetic acid, (54) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfonyl)methyl-1-naphthyloxy]acetic acid, (55) 2-{5-[3-(2RS-hydroxy-2-phenylethylthio)propyl]-1-naphthyloxy}acetic acid, (56) 2-[5-(2RS-hydroxy-3-phenoxypropylthio)-1-naphthyloxy]acetic acid, (57) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfinyl)-1-naphthyloxy]acetic acid, (58) 2-[5-(2RS-hydroxy-3-phenoxypropylsulfonyl)-1-naphthyloxy] acetic acid, (59) 2-[5-(3-styrylsulfinylpropyl)-1-naphthyloxy]acetic acid, (60) 2-[5-(3-styrylsulfonylpropyl)-1-naphthyloxy]acetic acid, (61) 2-{5-[2-(2RS-hydroxy-3-(4-chlorophenoxy)propylthio)ethyl]-1-naphthyloxy}acetic acid, (62) 2-{5-[2-(2RS-hydroxy-3-(4-methylphenoxy)propylthio)ethyl]-1-naphthyloxy}acetic acid, (63) 2-{5-[2-(2RS-hydroxy-3-(4-methyoxyphenoxy)propylthio)ethyl]-1-naphthyloxy}acetic acid, (64) 2-{5-[2-(2RS-hydroxy-3-diphenylmethoxypropylthio)ethyl]-1-naphthyloxy}-acetic acid, (65) 2-{5-[2-(2RS-hydroxy-3-phenylthiopropylthio)ethyl]-1-naphthyloxy}acetic acid, (66) 2-[5-(2RS-hydroxy-3-diphenylmethoxypropylthio) methyl-1-naphthyloxy]acetic acid, (67) 1-cyanlomethoxy-5-[2-(2RS-hydroxy-3-phenoxypropylthio)-ethyl]naphthalene, (68) 1-cyano methoxy-5-{2-[2RS-hydroxy-3-(4-chlorophenoxy)propylthio]ethyl}-naphthalene, (69) 1-cyanomethoxy-5-{2-[2RS-hydroxy-3-(4-methylphenoxy)propylthio]ethyl} naphthalene, (70) 1-cyanomethoxy-5-{2-[2RS-hydroxy-3-(4-methoxyphenoxy)-propylthio]ethyl}naphthalene, (71) 1-cyanomethoxy-5-[2-(2RS-hydroxy-3-diphenylmethoxypropylthio)-ethyl]naphthalene, (72) 1-cyanomethoxy-5-[2-(2RS-hydroxy-3-phenylthiopropylthio)-ethyl]naphthalene, (73) 1-cyanomethoxy-5-[(2RS-hydroxy-3-diphenylmethoxy)propylthiomethyl]-naphthalene, (74) 2-{5-[2-(2RS-hydroxy-3-(1-phenyl-1-(4-chlorophenyl)methoxy)propylthio)-ethyl]-1-naphthyloxy}ethanol, (75) 2-{5-[2-(2RS-hydroxy-3-phenylaminopropylthio)ethyl]-1-naphthyloxy}ethanol, (76) 1-(tetrazol-5-ylmethoxy)-5-{2-{2RS-hydroxy-3-(4-methyoxyphenoxy)-propylthio]ethyl}naphthalene, (77) N-methyl-{5-[2RS-hydroxy-3-(1-phenyl-1-(4-chlorophenyl)methoxy)-propylthio]methyl-1-naphthyloxy}acetic acid amide, (78) 1-{2-[5-hydroxy-1-(1,2,3,4-tetrahydronaphthyl)]ethylthio}-3-phenoxy-2RS-propanol, (79) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylthio)ethyl]-1-(5,6,7,8-tetrahydro-naphthyloxy)}acetic acid methyl ester, (80) 2-{5-[2-(2RS-hydroxy-3-phenoxypropylthio)ethyl]-1-(5,6,7,8-tetrahydro-naphthyloxy)}acetic acid or (81) 1-cyanomethoxy-5-[2-(2RS-hydroxy-3-phenoxypropylthio)ethyl]-5,6,7,8-tetrahydronaphthalene.
10 ) A compound according to claim 7 , which is
(1)1-[2-(5-hydroxy-1-naphthyl)ethoxy]-3-phenoxy-2RS-propanol, (2) 2-{5-[2-(2RS-hydroxy-3-phenoxypropoxy)ethyl]-1-naphthyloxy}acetic acid methyl ester or (3) 2-{5-[2-(2RS-hydroxy-3-phenoxypropoxy)ethyl]-1-naphthyloxy}acetic acid.
11 ) A compound according to claim 8 , which is
(1) 1-[2-(5-hydroxy-1-naphthyl)ethylamino]-3-phenoxy-2RS-propanol or (2) 2-{5-[2-(2RS-hydroxy-3-pheoxypropylamino)ethyl]-1-naphthyloxy}acetic acid.
12 ) A pharmaceutical composition which comprises a naphthyloxyacetic acid derivative of the formula (I) depicted in claim 1 , non-toxic salt thereof, non-toxic acid addition salt thereof or their hydrate.
13 ) A prostaglandin E2 antagonist or agonist which comprises a naphthyloxyacetic acid derivative of the formula (I) depicted in claim 1 , non-toxic salt thereof, non-toxic acid addition salt thereof or their hydrate.Join the waitlist — get patent alerts
Track US2003023096A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.